Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe Chanson

Showing results (121-130 of 363) with videos related to

Pageof 37
Sort By:
Annales D'Endocrinologie|November 25, 2015
Pegvisomant treatment in patients with acromegaly in clinical practice: The French ACROSTUDYPhilippe Chanson, Thierry Brue, Brigitte Delemer, et al.
Annales D'Endocrinologie|June 15, 2015
Management of clinically non-functioning pituitary adenomaPhilippe Chanson, Gerald Raverot, Frédéric Castinetti, et al.
Pituitary|March 1, 2013
Prevalence and risk factors of impaired glucose tolerance and diabetes mellitus at diagnosis of acromegaly: a study in 148 patientsOrsalia Alexopoulou, Marie Bex, Peter Kamenicky, et al.
European Journal of Endocrinology|November 18, 2021
Treatment of acromegaly has substantial effects on body composition: a long-term follow-up studyPeter Wolf, Sylvie Salenave, Emmanuel Durand, et al.
European Journal of Endocrinology|April 29, 2021
Apoplexy of microprolactinomas during pregnancy: report of five cases and review of the literatureEmmanuelle Kuhn, Alexandra A Weinreich, Nienke R Biermasz, et al.
The Journal of Clinical Endocrinology and Metabolism|October 26, 2006
Cardiac effects of growth hormone treatment in chronic heart failure: A meta-analysisPhilippe Le Corvoisier, Luc Hittinger, Philippe Chanson, et al.
Endocrine Connections|October 21, 2022
Impairment in insulin secretion without changes in insulin resistance explains hyperglycemia in patients with acromegaly treated with pasireotide LARPeter Wolf, Alexandre Dormoy, Luigi Maione, et al.
Drug Design, Development and Therapy|May 30, 2017
Ten years' clinical experience with biosimilar human growth hormone: a review of efficacy dataJuan Pedro López-Siguero, Roland Pfäffle, Philippe Chanson, et al.
Clinical Endocrinology|September 1, 2007
Pregnancy outcomes following cabergoline treatment: extended results from a 12-year observational studyAnnamaria Colao, Roger Abs, David González Bárcena, et al.
Neuroendocrinology|December 8, 2015
Germline Prolactin Receptor Mutation Is Not a Major Cause of Sporadic Prolactinoma in HumansValérie Bernard, Justine Bouilly, Isabelle Beau, et al.
Pageof 37

Showing results (121-130 of 363) with videos related to

Sort By:
Pageof 37
Annales D'Endocrinologie|November 25, 2015
Pegvisomant treatment in patients with acromegaly in clinical practice: The French ACROSTUDYPhilippe Chanson, Thierry Brue, Brigitte Delemer, et al.
Annales D'Endocrinologie|June 15, 2015
Management of clinically non-functioning pituitary adenomaPhilippe Chanson, Gerald Raverot, Frédéric Castinetti, et al.
Pituitary|March 1, 2013
Prevalence and risk factors of impaired glucose tolerance and diabetes mellitus at diagnosis of acromegaly: a study in 148 patientsOrsalia Alexopoulou, Marie Bex, Peter Kamenicky, et al.
European Journal of Endocrinology|November 18, 2021
Treatment of acromegaly has substantial effects on body composition: a long-term follow-up studyPeter Wolf, Sylvie Salenave, Emmanuel Durand, et al.
European Journal of Endocrinology|April 29, 2021
Apoplexy of microprolactinomas during pregnancy: report of five cases and review of the literatureEmmanuelle Kuhn, Alexandra A Weinreich, Nienke R Biermasz, et al.
The Journal of Clinical Endocrinology and Metabolism|October 26, 2006
Cardiac effects of growth hormone treatment in chronic heart failure: A meta-analysisPhilippe Le Corvoisier, Luc Hittinger, Philippe Chanson, et al.
Endocrine Connections|October 21, 2022
Impairment in insulin secretion without changes in insulin resistance explains hyperglycemia in patients with acromegaly treated with pasireotide LARPeter Wolf, Alexandre Dormoy, Luigi Maione, et al.
Drug Design, Development and Therapy|May 30, 2017
Ten years' clinical experience with biosimilar human growth hormone: a review of efficacy dataJuan Pedro López-Siguero, Roland Pfäffle, Philippe Chanson, et al.
Clinical Endocrinology|September 1, 2007
Pregnancy outcomes following cabergoline treatment: extended results from a 12-year observational studyAnnamaria Colao, Roger Abs, David González Bárcena, et al.
Neuroendocrinology|December 8, 2015
Germline Prolactin Receptor Mutation Is Not a Major Cause of Sporadic Prolactinoma in HumansValérie Bernard, Justine Bouilly, Isabelle Beau, et al.
Pageof 37